Press releases
17/03/2008
Antisoma to present at Cowen and Company Conference
17 March 2008, London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive, Glyn Edwards, will be presenting at the Cowen and Company 28th Annual Healthcare Conference in Boston on Thursday, March 20, 2008 at 11.00 am Eastern Time (3.00 pm GMT).
A webcast of the presentation will be available to all on Antisoma’s website at www.antisoma.com.
For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.
Enquiries:
Daniel Elger
Director of Communications
Antisoma plc
+44 7909 915 068
Brian Korb
The Trout Group
+1 212 477 9007
Background on Antisoma
Headquartered in London, UK, Antisoma is a biopharmaceutical
company that develops novel products for the treatment of cancer.
Antisoma fills its development pipeline by acquiring promising new
product candidates from internationally recognised academic or
cancer research institutions. Its core activity is the preclinical
and clinical development of these drug candidates. Please visit
www.antisoma.com
for further information.
Back to top